Tehran University of Medical Sciences

Science Communicator Platform

Share By
Therapeutic Potentials and Candidates for Covid-19 Publisher



Rezghi Rami M1 ; Meskini M2, 3, 4 ; Rezaei Khozani N5 ; Forouzandehdel S6 ; Momtaz S7, 8, 9 ; Ghosh S10 ; Rezaei N4, 11, 12 ; Abdolghaffari AH9, 13
Authors

Source: Iranian Journal of Science Published:2023


Abstract

The current coronavirus disease 2019 (COVID-19) outbreak spread rapidly worldwide. Yet, there is no identifiable antiviral treatment, so an effective drug is urgently needed. Preventive strategies and oxygen therapy are the main practical approaches to prevent and treat COVID-19. Clinical trials are in progress for the antiviral and immunomodulation agents that eventually are being developed for COVID-19 treatment. Pharmacological, immunotherapies, natural-based supplements, biologics, and combination therapies interventions have been established. The concept of drug repurposing was re-visited, and many conventional antivirals or immunosuppresses were evaluated for Efficacy against COVID-19 infection. Even though much has been published, the rapid progression of therapeutic strategies and unpredictable disease alterations necessitates continual information updates. This review defines drug repurposing and summarizes a medication developed for other therapeutic approaches rather than SARS-CoV-2 treatment. Furthermore, we provide data on the effectiveness of traditional Chinese medicines (TCM) on COVID-19. Additionally, biological and advanced Nano-based drug delivery systems are reviewed. © 2023, The Author(s), under exclusive licence to Shiraz University.
Other Related Docs
11. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
17. Traditional Persian Medicine As a Holistic Therapeutic Approach for Managing Covid-19, Traditional Medicines and Natural Products as Preventive and Therapeutic Agents against COVID-19: a Promising Response to the Global Unprecedented Pandemic (2024)
18. Covid-19: General Strategies for Herbal Therapies, Journal of Evidence-Based Integrative Medicine (2022)